{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:27:57Z","timestamp":1784356077330,"version":"3.55.0"},"reference-count":238,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013003","name":"University of Cagliari","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PE00000019"],"award-info":[{"award-number":["PE00000019"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jmgm.2025.109264","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T16:18:10Z","timestamp":1766247490000},"page":"109264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Computational studies of target-specific radiopharmaceuticals for theranostics"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5731-3396","authenticated-orcid":false,"given":"Silvia","family":"Gervasoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7679-6047","authenticated-orcid":false,"given":"Camilla","family":"Guccione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5985-257X","authenticated-orcid":false,"given":"Giuliano","family":"Malloci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jmgm.2025.109264_b1","article-title":"Small molecule radiopharmaceuticals \u2013 a review of current approaches","volume":"3","author":"Chaturvedi","year":"2016","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.jmgm.2025.109264_b2","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1021\/acs.chemrev.8b00281","article-title":"Radioactive transition metals for imaging and therapy","volume":"119","author":"Boros","year":"2019","journal-title":"Chem. Rev."},{"issue":"2","key":"10.1016\/j.jmgm.2025.109264_b3","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1021\/acs.chemrev.8b00294","article-title":"Radioactive main group and rare earth metals for imaging and therapy","volume":"119","author":"Kostelnik","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jmgm.2025.109264_b4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-024-02041-6","article-title":"Radiopharmaceuticals and their applications in medicine","volume":"10","author":"Zhang","year":"2025","journal-title":"Sig. Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.jmgm.2025.109264_b5","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1021\/acsptsci.3c00081","article-title":"Druggability of targets for diagnostic radiopharmaceuticals","volume":"6","author":"Wang","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"18","key":"10.1016\/j.jmgm.2025.109264_b6","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.3390\/molecules29184416","article-title":"Force fields, quantum-mechanical- and molecular-dynamics-based descriptors of radiometal\u2013chelator complexes","volume":"29","author":"\u00d6zt\u00fcrk","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2025.109264_b7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40001-023-01627-0","article-title":"Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation","volume":"29","author":"Dhoundiyal","year":"2024","journal-title":"Eur. J. Med. Res."},{"issue":"3","key":"10.1016\/j.jmgm.2025.109264_b8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/ph12030114","article-title":"Lutathera\u00ae: The first fda- and ema-approved radiopharmaceutical for peptide receptor radionuclide therapy","volume":"12","author":"Hennrich","year":"2019","journal-title":"Pharmaceuticals"},{"issue":"11","key":"10.1016\/j.jmgm.2025.109264_b9","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.3390\/cancers15112975","article-title":"Peptide receptor radionuclide therapy (prrt): Innovations and improvements","volume":"15","author":"Merola","year":"2023","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.jmgm.2025.109264_b10","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1021\/cbmi.4c00030","article-title":"Peptide pet imaging: A review of recent developments and a look at the future of radiometal-labeled peptides in medicine","volume":"2","author":"Shabsigh","year":"2024","journal-title":"Chem. Biomed. Imaging"},{"issue":"3","key":"10.1016\/j.jmgm.2025.109264_b11","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1021\/acs.molpharmaceut.4c01293","article-title":"Development of novel peptide-based radiotracers for detecting fgl1 expression in tumors","volume":"22","author":"Xu","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jmgm.2025.109264_b12","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s41597-024-03707-0","article-title":"An improved dataset of force fields, electronic and physicochemical descriptors of metabolic substrates","volume":"11","author":"Macorano","year":"2024","journal-title":"Sci. Data"},{"key":"10.1016\/j.jmgm.2025.109264_b13","doi-asserted-by":"crossref","DOI":"10.3389\/fbinf.2022.1046493","article-title":"Towards rational computational peptide design","volume":"2","author":"Chang","year":"2022","journal-title":"Front. Bioinform."},{"issue":"7","key":"10.1016\/j.jmgm.2025.109264_b14","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.3390\/ijms24076856","article-title":"Computer-assisted design of peptide-based radiotracers","volume":"24","author":"Patamia","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmgm.2025.109264_b15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-020-0073-9","article-title":"Radiopharmaceutical therapy in cancer: clinical advances and challenges","volume":"19","author":"Sgouros","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.jmgm.2025.109264_b16","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1016\/S1470-2045(24)00030-5","article-title":"Recent advances and impending challenges for the radiopharmaceutical sciences in oncology","volume":"25","author":"Lapi","year":"2024","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.jmgm.2025.109264_b17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/pro6.1239","article-title":"Revolutionizing cancer treatment: The role of radiopharmaceuticals in modern cancer therapy","volume":"8","author":"Varghese","year":"2024","journal-title":"Precis. Radiat. Oncol."},{"issue":"4","key":"10.1016\/j.jmgm.2025.109264_b18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/1874471015666220831091403","article-title":"Discovery and design of radiopharmaceuticals by in silico methods","volume":"15","author":"Salahinejad","year":"2022","journal-title":"Curr. Radiopharm."},{"issue":"12","key":"10.1016\/j.jmgm.2025.109264_b19","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1021\/acschemneuro.2c00269","article-title":"In silico approaches for addressing challenges in cns radiopharmaceutical design","volume":"13","author":"Jackson","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jmgm.2025.109264_b20","first-page":"2211","article-title":"Artificial intelligence for radiopharmaceutical and molecular imaging","author":"Tao","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.jmgm.2025.109264_b21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cpet.2021.06.008","article-title":"Artificial intelligence and the future of diagnostic and therapeutic radiopharmaceutical development: in silico smart molecular design","volume":"16","author":"Ataeinia","year":"2022","journal-title":"PET Clin."},{"issue":"14","key":"10.1016\/j.jmgm.2025.109264_b22","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1021\/jm500416f","article-title":"64cu-labeled somatostatin analogues conjugated with cross-bridged phosphonate-based chelators via strain-promoted click chemistry for pet imaging: In silico through in vivo studies","volume":"57","author":"Cai","year":"2014","journal-title":"J. Med. Chem."},{"issue":"15","key":"10.1016\/j.jmgm.2025.109264_b23","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1021\/acs.jcim.3c00712","article-title":"Interaction of radiopharmaceuticals with somatostatin receptor 2 revealed by molecular dynamics simulations","volume":"63","author":"Gervasoni","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2025.109264_b24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13550-018-0387-3","article-title":"Structural studies on radiopharmaceutical dota-minigastrin analogue (cp04) complexes and their interaction with cck2 receptor","volume":"8","author":"Lipi\u0144ski","year":"2018","journal-title":"EJNMMI Res."},{"issue":"7","key":"10.1016\/j.jmgm.2025.109264_b25","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1021\/acs.molpharmaceut.2c00070","article-title":"Investigation of tumor cells and receptor\u2013ligand simulation models for the development of pet imaging probes targeting psma and grpr and a possible crosstalk between the two receptors","volume":"19","author":"Liolios","year":"2022","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.jmgm.2025.109264_b26","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.3390\/ijms23042005","article-title":"All-atom molecular dynamics investigations on the interactions between d2 subunit dopamine receptors and three 11c-labeled radiopharmaceutical ligands","volume":"23","author":"Moldovean","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.jmgm.2025.109264_b27","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/cn300142q","article-title":"Comparison of the binding and functional properties of two structurally different d2 dopamine receptor subtype selective compounds","volume":"3","author":"Luedtke","year":"2012","journal-title":"ACS Chem. Neurosci."},{"issue":"21","key":"10.1016\/j.jmgm.2025.109264_b28","doi-asserted-by":"crossref","first-page":"7648","DOI":"10.1021\/jm2009716","article-title":"Design, synthesis, and functionalization of dimeric peptides targeting chemokine receptor cxcr4","volume":"54","author":"Demmer","year":"2011","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.jmgm.2025.109264_b29","doi-asserted-by":"crossref","first-page":"8484","DOI":"10.1021\/acs.jmedchem.3c00131","article-title":"Development of a new class of cxcr4-targeting radioligands based on the endogenous antagonist epi-x4 for oncological applications","volume":"66","author":"Gaonkar","year":"2023","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.jmgm.2025.109264_b30","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3390\/ijms23031214","article-title":"Novel nk1r-targeted 68ga-\/177lu-radioconjugates with potential application against glioblastoma multiforme: Preliminary exploration of structure\u2013activity relationships","volume":"23","author":"Matali\u0144ska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.jmgm.2025.109264_b31","article-title":"A 211at-labelled mglur1 inhibitor induces cancer senescence to elicit long-lasting anti-tumor efficacy","volume":"4","author":"Xie","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"8","key":"10.1016\/j.jmgm.2025.109264_b32","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1021\/acsptsci.4c00261","article-title":"Radiosynthesis and evaluation of 11c-labeled isoindolone-based positive allosteric modulators for positron emission tomography imaging of metabotropic glutamate receptor 2","volume":"7","author":"Li","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"9","key":"10.1016\/j.jmgm.2025.109264_b33","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1021\/acs.bioconjchem.3c00265","article-title":"Synthesis and 177lu labeling of the first retro analog of the her2-targeting a9 peptide: A superior variant","volume":"34","author":"Sharma","year":"2023","journal-title":"Bioconjugate Chem."},{"issue":"8","key":"10.1016\/j.jmgm.2025.109264_b34","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3390\/pr12081659","article-title":"Radioiodinated anastrozole and epirubicin for her2-targeted cancer therapy: Molecular docking and dynamics insights with implications for nuclear imaging","volume":"12","author":"Binmujlli","year":"2024","journal-title":"Processes"},{"key":"10.1016\/j.jmgm.2025.109264_b35","first-page":"11","article-title":"Radiosynthesis, biological evaluation, and preclinical study of a 68ga-labeled cyclic rgd peptide as an early diagnostic agent for overexpressed \u03b1v\u03b23 integrin receptors in non-small-cell lung cancer","volume":"8421657","author":"Pirooznia","year":"2020","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.jmgm.2025.109264_b36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107892","article-title":"Development and preclinical evaluation of a cyclic pet tracer targeting integrin-\u03b16 on colorectal cancer models","volume":"153","author":"Chen","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.jmgm.2025.109264_b37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00259-021-05617-4","article-title":"Radiosynthesis and characterization of [18f]bs224: a next-generation tspo pet ligand insensitive to the rs6971 polymorphism","volume":"49","author":"Lee","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"10","key":"10.1016\/j.jmgm.2025.109264_b38","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1021\/acs.jmedchem.3c00309","article-title":"Design and characterization of squaramic acid\u2013based prostate-specific membrane antigen inhibitors for prostate cancer","volume":"66","author":"Wang","year":"2023","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.jmgm.2025.109264_b39","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1021\/acsmedchemlett.4c00324","article-title":"Synthesis and preclinical evaluation of a bispecific psma-617\/rm2 heterodimer targeting prostate cancer","volume":"15","author":"Liolios","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"issue":"15","key":"10.1016\/j.jmgm.2025.109264_b40","doi-asserted-by":"crossref","first-page":"13392","DOI":"10.1021\/acs.jmedchem.4c01295","article-title":"Molecular evolution of multivalent oncofap derivatives with enhanced tumor uptake and prolonged tumor retention","volume":"67","author":"Galbiati","year":"2024","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.jmgm.2025.109264_b41","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1021\/acs.bioconjchem.4c00214","article-title":"Development of an fap-targeted pet probe based on a novel quinolinium molecular scaffold","volume":"35","author":"Li","year":"2024","journal-title":"Bioconjugate Chem."},{"issue":"4","key":"10.1016\/j.jmgm.2025.109264_b42","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.70177","article-title":"Pioneering qsar modeling study of fap-targeting radiopharmaceuticals used in oncology","volume":"106","author":"Fatehi","year":"2025","journal-title":"Chem. Biol. Drug. Des."},{"key":"10.1016\/j.jmgm.2025.109264_b43","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bbrc.2016.12.156","article-title":"Rapid pd-l1 detection in tumors with pet using a highly specific peptide","volume":"483","author":"Chatterjee","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"29","key":"10.1016\/j.jmgm.2025.109264_b44","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1039\/C9CC00445A","article-title":"Developing native peptide-based radiotracers for pd-l1 pet imaging and improving imaging contrast by pegylatione","volume":"55","author":"Kuan","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jmgm.2025.109264_b45","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106785","article-title":"A novel 68ga-labeled cyclic peptide molecular probe based on the computer-aided design for noninvasive imaging of pd-l1 expression in tumors","volume":"140","author":"Ge","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jmgm.2025.109264_b46","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1007\/s00259-022-05876-9","article-title":"Preclinical and first-in-human evaluation of 18f-labeled d-peptide antagonist for pd-l1 status imaging with pet","volume":"49","author":"Zhou","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"12","key":"10.1016\/j.jmgm.2025.109264_b47","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.3390\/pharmaceutics15122662","article-title":"99Mtc-labeled cyclic peptide targeting pd-l1 as a novel nuclear imaging probe","volume":"15","author":"Ferro-Flores","year":"2023","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.jmgm.2025.109264_b48","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3390\/pharmaceutics17070920","article-title":"Synthesis and evaluation of [18f]alf-nota-ipd-l1 as a potential theranostic pair for [177lu]lu-dota-ipd-l1","volume":"17","author":"Ferro-Flores","year":"2025","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.jmgm.2025.109264_b49","first-page":"1","article-title":"Lutetium-177 labeled ipd-l1 as a novel immunomodulator for cancer-targeted radiotherapy","volume":"10","author":"Luna-Guti\u00e9rrez","year":"2025","journal-title":"EJNMMI Radiopharm. Chem."},{"issue":"4","key":"10.1016\/j.jmgm.2025.109264_b50","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3390\/pharmaceutics14040828","article-title":"Towards selective binding to the glut5 transporter: Synthesis, molecular dynamics and in vitro evaluation of novel c-3-modified 2 5-anhydro-d-mannitol analogs","volume":"14","author":"Rana","year":"2022","journal-title":"Pharmaceutics"},{"issue":"15","key":"10.1016\/j.jmgm.2025.109264_b51","doi-asserted-by":"crossref","first-page":"8134","DOI":"10.3390\/app15158134","article-title":"Combining qsar and molecular docking for the methodological design of novel radiotracers targeting parkinson\u2019s disease","volume":"15","author":"Castillo-Garit","year":"2025","journal-title":"Appl. Sci."},{"key":"10.1016\/j.jmgm.2025.109264_b52","doi-asserted-by":"crossref","first-page":"12084","DOI":"10.1038\/srep12084","article-title":"Preliminary characterization and in vivo studies of structurally identical 18f- and 125i-labeled benzyloxybenzenes for pet\/spect imaging of \u03b2-amyloid plaques","volume":"5","author":"Yang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2025.109264_b53","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s11307-023-01814-9","article-title":"Identification of a putative \u03b1-synuclein radioligand using an in silico similarity search","volume":"25","author":"Janssen","year":"2023","journal-title":"Mol. Imaging. Biol."},{"issue":"8","key":"10.1016\/j.jmgm.2025.109264_b54","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1021\/acs.molpharmaceut.8b00229","article-title":"In silico, in vitro, and in vivo evaluation of new candidates for \u03b1-synuclein pet imaging","volume":"15","author":"Verdurand","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jmgm.2025.109264_b55","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemolab.2024.105278","article-title":"A review of quantitative structure\u2013activity relationship: The development and current status of data sets, molecular descriptors and mathematical models","volume":"256","author":"Li","year":"2025","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"10.1016\/j.jmgm.2025.109264_b56","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1016\/j.csbj.2020.11.007","article-title":"Homology modeling in the time of collective and artificial intelligence","volume":"18","author":"Hameduh","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"18","key":"10.1016\/j.jmgm.2025.109264_b57","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.3390\/ijms20184331","article-title":"Molecular docking: Shifting paradigms in drug discovery","volume":"20","author":"Pinzi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmgm.2025.109264_b58","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1741-7007-9-71","article-title":"Molecular dynamics simulations and drug discovery","volume":"9","author":"Durrant","year":"2011","journal-title":"BMC Biol."},{"key":"10.1016\/j.jmgm.2025.109264_b59","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.712085","article-title":"Recent developments in free energy calculations for drug discovery","volume":"8","author":"King","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"4","key":"10.1016\/j.jmgm.2025.109264_b60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/mol.117.111062","article-title":"G protein-coupled receptors as targets for approved drugs: How many targets and how many drugs?","volume":"93","author":"Sriram","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jmgm.2025.109264_b61","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-020-00435-w","article-title":"G protein-coupled receptors: structure- and function-based drug discovery","volume":"6","author":"Yang","year":"2021","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.jmgm.2025.109264_b62","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fnmol.2019.00255","article-title":"Is there a role for gpcr agonist radiotracers in pet neuroimaging?","volume":"12","author":"Colom","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jmgm.2025.109264_b63","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41392-024-01803-6","article-title":"G protein-coupled receptors (gpcrs): advances in structures, mechanisms and drug discovery","volume":"9","author":"Zhang","year":"2024","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.jmgm.2025.109264_b64","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2019.105524","article-title":"Expression and purification of recombinant g protein-coupled receptors: A review","volume":"167","author":"Wiseman","year":"2020","journal-title":"Protein Expr. Purif."},{"issue":"3","key":"10.1016\/j.jmgm.2025.109264_b65","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41594-022-00727-5","article-title":"Plasticity in ligand recognition at somatostatin receptors","volume":"29","author":"Robertson","year":"2022","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jmgm.2025.109264_b66","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1038\/s41598-023-31823-1","article-title":"Molecular simulations of sstr2 dynamics and interaction with ligands","volume":"13","author":"Gervasoni","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2025.109264_b67","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.csbj.2024.03.005","article-title":"Exploring key features of selectivity in somatostatin receptors through molecular dynamics simulations","volume":"23","author":"Guccione","year":"2024","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"4","key":"10.1016\/j.jmgm.2025.109264_b68","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1021\/jm020406h","article-title":"Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine","volume":"46","author":"Jain","year":"2003","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.jmgm.2025.109264_b69","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1039\/C3CC45928D","article-title":"New cross-bridged cyclam derivative cb-te1k1p, an improved bifunctional chelator for copper radionuclides","volume":"50","author":"Zeng","year":"2014","journal-title":"Chem. Commun. (Camb)"},{"key":"10.1016\/j.jmgm.2025.109264_b70","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature11085","article-title":"Structure of the nociceptin\/orphanin fq receptor in complex with a peptide mimetic","volume":"485","author":"Thompson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jmgm.2025.109264_b71","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature10954","article-title":"Crystal structure of the mu-opioid receptor bound to a morphinan antagonist","volume":"485","author":"Manglik","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jmgm.2025.109264_b72","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature10939","article-title":"Structure of the human kappa-opioid receptor in complex with jdtic","volume":"485","author":"Wu","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jmgm.2025.109264_b73","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature11111","article-title":"Structure of the delta opioid receptor bound to naltrindole","volume":"485","author":"Granier","year":"2012","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.jmgm.2025.109264_b74","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1093\/nar\/gkg543","article-title":"Tools for comparative protein structure modeling and analysis","volume":"31","author":"Eswar","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2025.109264_b75","series-title":"Advances in Scientific Visualization","first-page":"58","article-title":"Molcad\u2014computer aided visualization and manipulation of models in molecular science","author":"Waldherr-Teschner","year":"1992"},{"issue":"4","key":"10.1016\/j.jmgm.2025.109264_b76","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1021\/acs.jcim.5b00674","article-title":"Mcpb.py: A python based metal center parameter builder","volume":"56","author":"Li","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2025.109264_b77","first-page":"3823","article-title":"Amber2020, University of California, San Fransisco","volume":"142","author":"Case","year":"2020","journal-title":"J. Amer. Chem. Soc."},{"key":"10.1016\/j.jmgm.2025.109264_b78","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1107\/S2052520616003954","article-title":"The cambridge structural database","volume":"72","author":"Groom","year":"2016","journal-title":"Acta Crystsllogr. B Struct. Sci. Cryst. Eng. Mater. B"},{"issue":"3","key":"10.1016\/j.jmgm.2025.109264_b79","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1021\/acs.chemrev.6b00440","article-title":"Metal ion modeling using classical mechanics","volume":"117","author":"Li","year":"2017","journal-title":"Chem. Rev."},{"issue":"11","key":"10.1016\/j.jmgm.2025.109264_b80","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"Charmm-gui: a web-based graphical user interface for charmm","volume":"29","author":"Jo","year":"2008","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2025.109264_b81","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13321-021-00548-6","article-title":"Prolif: a library to encode molecular interactions as fingerprints","volume":"13","author":"Bouysset","year":"2021","journal-title":"J. Cheminform."},{"key":"10.1016\/j.jmgm.2025.109264_b82","first-page":"112","article-title":"Gastrin, cholecystokinin, signaling, and biological activities in cellular processes","volume":"11","author":"Zeng","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2025.109264_b83","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/s41589-021-00866-8","article-title":"Structures of the human cholecystokinin receptors bound to agonists and antagonists","volume":"17","author":"Zhang","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jmgm.2025.109264_b84","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41421-022-00420-3","article-title":"Structural insights into human brain\u2013gut peptide cholecystokinin receptors","volume":"5","author":"Ding","year":"2022","journal-title":"Cell Discov."},{"issue":"Web Server issue","key":"10.1016\/j.jmgm.2025.109264_b85","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"Swiss-model: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.jmgm.2025.109264_b86","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Autodock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"6","key":"10.1016\/j.jmgm.2025.109264_b87","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2967\/jnumed.119.234971","article-title":"Imaging the distribution of gastrin-releasing peptide receptors in cancer","volume":"61","author":"Baratto","year":"2020","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jmgm.2025.109264_b88","article-title":"Novel insight on grp\/grpr axis in diseases","volume":"161","author":"l. Sun","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.jmgm.2025.109264_b89","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jcp.2003.10660","article-title":"Gastrin releasing peptide and gastrin releasing peptide receptor expression in gastrointestinal carcinoid tumours","volume":"57","author":"Scott","year":"2004","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jmgm.2025.109264_b90","doi-asserted-by":"crossref","first-page":"13315","DOI":"10.1038\/s41598-021-92528-x","article-title":"The gastrin-releasing peptide\/bombesin system revisited by a reverse-evolutionary study considering xenopus","volume":"11","author":"Hirooka","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jmgm.2025.109264_b91","article-title":"Gastrin-releasing peptide receptor (grpr) as a novel biomarker and therapeutic target in prostate cancer","volume":"56","author":"Zhang","year":"2024","journal-title":"Ann. Med."},{"key":"10.1016\/j.jmgm.2025.109264_b92","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21087-6","article-title":"Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation","volume":"12","author":"Hong","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmgm.2025.109264_b93","series-title":"Schr\u00f6dinger release 2025-1: Maestro","author":"S. L. N. Y. (NY)","year":"2025"},{"issue":"2","key":"10.1016\/j.jmgm.2025.109264_b94","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3390\/biomedicines9020109","article-title":"Dopamine in health and disease: Much more than a neurotransmitter","volume":"9","author":"Franco","year":"2021","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.jmgm.2025.109264_b95","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/receptors3020009","article-title":"Dopamine d1\u2013d5 receptors in brain nuclei: Implications for health and disease","volume":"3","author":"Kawahata","year":"2024","journal-title":"Receptors"},{"issue":"W1","key":"10.1016\/j.jmgm.2025.109264_b96","doi-asserted-by":"crossref","first-page":"W324","DOI":"10.1093\/nar\/gkae300","article-title":"Swissdock 2024: major enhancements for small-molecule docking with attracting cavities and autodock vina","volume":"52","author":"M.","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2025.109264_b97","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00249-011-0700-9","article-title":"Definition and testing of the gromos force-field versions 54a7 and 54b7","volume":"40","author":"Schmid","year":"2011","journal-title":"Eur. Biophys. J."},{"issue":"12","key":"10.1016\/j.jmgm.2025.109264_b98","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1021\/cr5004419","article-title":"The oniom method and its applications","volume":"115","author":"Chung","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jmgm.2025.109264_b99","series-title":"Gaussian 16 Revision C.01","author":"Frisch","year":"2016"},{"issue":"3","key":"10.1016\/j.jmgm.2025.109264_b100","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.bmc.2005.09.008","article-title":"Synthesis and characterization of selective dopamine d2 receptor antagonists","volume":"14","author":"Vangveravong","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"11","key":"10.1016\/j.jmgm.2025.109264_b101","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1021\/ci1002747","article-title":"Subtype selectivity of dopamine receptor ligands: Insights from structure and ligand-based methods","volume":"50","author":"Wang","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2025.109264_b102","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature25758","article-title":"Structure of the d2 dopamine receptor bound to the atypical antipsychotic drug risperidone","volume":"555","author":"Wang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jmgm.2025.109264_b103","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41586-020-2379-5","article-title":"Structure of a d2 dopamine receptor\u2013g-protein complex in a lipid membrane","volume":"584","author":"Yin","year":"2020","journal-title":"Nature"},{"issue":"6007","key":"10.1016\/j.jmgm.2025.109264_b104","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1126\/science.1197410","article-title":"Structure of the human dopamine d3 receptor in complex with a d2\/d3 selective antagonist","volume":"330","author":"Chien","year":"2010","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.jmgm.2025.109264_b105","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2021.01.003","article-title":"Structures of the human dopamine d3 receptor-gi complexes","volume":"81","author":"Xu","year":"2021","journal-title":"Mol. Cell."},{"issue":"3","key":"10.1016\/j.jmgm.2025.109264_b106","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmgm.2025.109264_b107","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.3389\/fimmu.2020.02109","article-title":"The chemokine receptor cxcr4 in cell proliferation and tissue regeneration","volume":"11","author":"Bianchi","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.jmgm.2025.109264_b108","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1021\/bc060154p","article-title":"Rigid linkers for bioactive peptides","volume":"17","author":"Vagner","year":"2006","journal-title":"Bioconjugate Chem."},{"issue":"6007","key":"10.1016\/j.jmgm.2025.109264_b109","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.1194396","article-title":"Structures of the cxcr4 chemokine gpcr with small-molecule and cyclic peptide antagonists","volume":"330","author":"Wu","year":"2010","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.jmgm.2025.109264_b110","doi-asserted-by":"crossref","first-page":"7106","DOI":"10.1021\/acs.jctc.1c00810","article-title":"Efficient exploration of chemical space with docking and deep learning","volume":"17","author":"Yang","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jmgm.2025.109264_b111","doi-asserted-by":"crossref","first-page":"6996","DOI":"10.1093\/emboj\/16.23.6996","article-title":"Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of cxcr4 activation from binding and inhibition of hiv-1","volume":"16","author":"Crump","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.jmgm.2025.109264_b112","doi-asserted-by":"crossref","first-page":"6439","DOI":"10.1038\/s41467-023-42082-z","article-title":"Structural basis of dimerization of chemokine receptors ccr5 and cxcr4","volume":"14","author":"Marino","year":"2023","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.jmgm.2025.109264_b113","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jmb.2015.09.014","article-title":"The haddock2. 2 web server: user-friendly integrative modeling of biomolecular complexes","volume":"428","author":"Van Zundert","year":"2016","journal-title":"J. Mol. Biol."},{"issue":"24","key":"10.1016\/j.jmgm.2025.109264_b114","doi-asserted-by":"crossref","first-page":"16801","DOI":"10.1021\/acs.jmedchem.2c01605","article-title":"Discovery and optimization of potent, selective, and brain-penetrant 1-heteroaryl-1 h-indazole lrrk2 kinase inhibitors for the treatment of parkinson\u2019s disease","volume":"65","author":"Candito","year":"2022","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.jmgm.2025.109264_b115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1021\/acs.jctc.6b00931","article-title":"Gaussian accelerated molecular dynamics in namd","volume":"132","author":"Pang","year":"2017","journal-title":"J. Chem. Theory Comput."},{"issue":"49","key":"10.1016\/j.jmgm.2025.109264_b116","doi-asserted-by":"crossref","first-page":"15039","DOI":"10.1021\/ja037236y","article-title":"Crystal structures of two complexes of the rare-earth-dota-binding antibody 2d12.5: Ligand generality from a chiral system","volume":"125","author":"Corneillie","year":"2003","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.jmgm.2025.109264_b117","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2016-000144","article-title":"Hallmarks of glioblastoma: a systematic review","volume":"1","author":"N\u00f8r\u00f8xe","year":"2017","journal-title":"ESMO Open"},{"key":"10.1016\/j.jmgm.2025.109264_b118","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13046-022-02349-7","article-title":"Emerging therapies for glioblastoma: current state and future directions","volume":"41","author":"Rong","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jmgm.2025.109264_b119","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6291504","article-title":"The neurokinin-1 receptor is essential for the viability of human glioma cells: A possible target for treating glioblastoma","volume":"2022","author":"Mu\u00f1oz","year":"2022","journal-title":"Biomed Res. Int."},{"issue":"1","key":"10.1016\/j.jmgm.2025.109264_b120","first-page":"1344","article-title":"In vitro evaluation of 225ac-dota-substance p for targeted alpha therapy of glioblastoma multiforme","volume":"92","author":"Pilip","year":"2018","journal-title":"Biomed Res. Int."},{"issue":"14","key":"10.1016\/j.jmgm.2025.109264_b121","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1021\/jm00066a015","article-title":"N-acyl-l-tryptophan benzyl esters: potent substance p receptor antagonists","volume":"36","author":"MacLeod","year":"1993","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.jmgm.2025.109264_b122","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"Autodock4 and autodocktools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2025.109264_b123","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41467-018-07939-8","article-title":"Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists","volume":"10","author":"Sch\u00f6ppe","year":"2019","journal-title":"Nat. Commun."},{"issue":"D1","key":"10.1016\/j.jmgm.2025.109264_b124","doi-asserted-by":"crossref","first-page":"D440","DOI":"10.1093\/nar\/gkx1109","article-title":"Gpcrdb in 2018: adding gpcr structure models and ligands","volume":"46","author":"P\u00e1ndy-Szekeres","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.jmgm.2025.109264_b125","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.neuron.2018.05.018","article-title":"Glutamatergic signaling in the central nervous system: Ionotropic and metabotropic receptors in concert","volume":"98","author":"Reiner","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.jmgm.2025.109264_b126","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fnmol.2019.00020","article-title":"Role of metabotropic glutamate receptors in neurological disorders","volume":"12","author":"Crupi","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.jmgm.2025.109264_b127","first-page":"534","article-title":"A phase ii trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (grm1) signaling, in patients with advanced melanoma","volume":"31","author":"Mehnert","year":"2018","journal-title":"Cell Rep. Med."},{"issue":"6179","key":"10.1016\/j.jmgm.2025.109264_b128","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1249489","article-title":"Structure of a class c gpcr metabotropic glutamate receptor 1 bound to an allosteric modulator","volume":"344","author":"Wu","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jmgm.2025.109264_b129","series-title":"Molecular operating environment (moe), chemical computing group inc 1010","author":"C. C. G. Inc","year":"2016"},{"issue":"1","key":"10.1016\/j.jmgm.2025.109264_b130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"Vmd: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.jmgm.2025.109264_b131","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-1-4939-7366-8_4","article-title":"Yasara: A tool to obtain structural guidance in biocatalytic investigations","volume":"1685","author":"Land","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"6807","key":"10.1016\/j.jmgm.2025.109264_b132","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/35039564","article-title":"Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor","volume":"407","author":"Kunishima","year":"2000","journal-title":"Nature"},{"issue":"7742","key":"10.1016\/j.jmgm.2025.109264_b133","doi-asserted-by":"crossref","first-page":"7984","DOI":"10.1038\/s41586-019-0881-4","article-title":"Structural insights into metabotropic glutamate receptor activation","volume":"566","author":"Koehl","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jmgm.2025.109264_b134","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40364-024-00565-1","article-title":"Her2-targeted therapies in cancer: a systematic review","volume":"12","author":"Zhu","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.jmgm.2025.109264_b135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","article-title":"Targeting her2-positive breast cancer: advances and future directions","volume":"22","author":"Swain","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jmgm.2025.109264_b136","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s13046-022-02515-x","article-title":"Her3 in cancer: from the bench to the bedside","volume":"41","author":"Gandullo-S\u00e1nchez","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jmgm.2025.109264_b137","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature01392","article-title":"Structure of the extracellular region of her2 alone and in complex with the herceptin fab","volume":"421","author":"Cho","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jmgm.2025.109264_b138","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fmolb.2017.00087","article-title":"Recent developments and applications of the mmpbsa method","volume":"4","author":"Wang","year":"2018","journal-title":"Front. Mol. Biosci."},{"issue":"23","key":"10.1016\/j.jmgm.2025.109264_b139","doi-asserted-by":"crossref","first-page":"8030","DOI":"10.1021\/jm2008634","article-title":"Design and synthesis of novel human epidermal growth factor receptor 2 (her2)\/epidermal growth factor receptor (egfr) dual inhibitors bearing a pyrrolo[3, 2-d]pyrimidine scaffold","volume":"54","author":"Ishikawa","year":"2011","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.jmgm.2025.109264_b140","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa\u2014a gromacs tool for high-throughput mm-pbsa calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2025.109264_b141","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106694","article-title":"The challenges and opportunities of \u03b1v\u03b23-based therapeutics in cancer: From bench to clinical trials","volume":"189","author":"Gu","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"5565","key":"10.1016\/j.jmgm.2025.109264_b142","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1126\/science.1069040","article-title":"Crystal structure of the extracellular segment of integrin \u03b1v\u03b23 in complex with an arg-gly-asp ligand","volume":"296","author":"Xiong","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jmgm.2025.109264_b143","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s41181-021-00141-0","article-title":"The aluminium-[18f]fluoride revolution: simple radiochemistry with a big impact for radiolabelled biomolecules","volume":"6","author":"Archibald","year":"2021","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"10.1016\/j.jmgm.2025.109264_b144","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1038\/s41467-021-24184-8","article-title":"Structural mechanism of laminin recognition by integrin","volume":"12","author":"Arimori","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmgm.2025.109264_b145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13062-015-0103-4","article-title":"Pepstrmod: structure prediction of peptides containing natural, non-natural and modified residues","volume":"10","author":"Singh","year":"2015","journal-title":"Biol. Direct"},{"issue":"12","key":"10.1016\/j.jmgm.2025.109264_b146","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/bioinformatics\/btu097","article-title":"Zdock server: interactive docking prediction of protein\u2013protein complexes and symmetric multimers","volume":"30","author":"Pierce","year":"2014","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.jmgm.2025.109264_b147","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5483\/BMBRep.2020.53.1.273","article-title":"Translocator protein (tspo): the new story of the old protein in neuroinflammation","volume":"53","author":"Lee","year":"2020","journal-title":"BMB Rep."},{"issue":"17","key":"10.1016\/j.jmgm.2025.109264_b148","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.3390\/molecules29174212","article-title":"Tspo radioligands for neuroinflammation: An overview","volume":"29","author":"Salerno","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2025.109264_b149","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.brainresbull.2016.02.001","article-title":"Tspo ligand pk11195 alleviates neuroinflammation and beta-amyloid generation induced by systemic lps administration","volume":"121","author":"Ma","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"2","key":"10.1016\/j.jmgm.2025.109264_b150","first-page":"1","article-title":"[123i]cc1: A parp-targeting, auger electron\u2013emitting radiopharmaceutical for radionuclide therapy of cancer","volume":"66","author":"Chan","year":"2025","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.jmgm.2025.109264_b151","first-page":"1","article-title":"New acetylcholinesterase inhibitors for alzheimer\u2019s disease","volume":"2012","author":"Mehta","year":"2012","journal-title":"Int. J. Alzheimer\u2019s Dis."},{"issue":"15","key":"10.1016\/j.jmgm.2025.109264_b152","doi-asserted-by":"crossref","first-page":"12509","DOI":"10.1021\/acsomega.1c04256","article-title":"[99mTc]tc-dtpa-bis(cholineethylamine) as an oncologic tracer for the detection of choline transporter (cht) and choline kinase (chk) expression in cancer","volume":"7","author":"Jaswal","year":"2022","journal-title":"ACS Omega"},{"issue":"2","key":"10.1016\/j.jmgm.2025.109264_b153","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jmb.2006.08.084","article-title":"Elucidation of human choline kinase crystal structures in complex with the products adp or phosphocholine","volume":"364","author":"Malito","year":"2006","journal-title":"J. Mol. Biology"},{"key":"10.1016\/j.jmgm.2025.109264_b154","series-title":"Open babel 2.4.0","author":"O. B. development team","year":"2016"},{"key":"10.1016\/j.jmgm.2025.109264_b155","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1007\/s00259-023-06249-6","article-title":"Pet imaging of parp expression using 68ga-labelled inhibitors","volume":"50","author":"Wang","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"5","key":"10.1016\/j.jmgm.2025.109264_b156","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.molcel.2015.10.013","article-title":"Parp-1 activation requires local unfolding of an autoinhibitory domain","volume":"60","author":"Dawicki-McKenna","year":"2015","journal-title":"Mol. Cell."},{"issue":"8950","key":"10.1016\/j.jmgm.2025.109264_b157","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0140-6736(95)90526-X","article-title":"Tacrine","volume":"345","author":"Davis","year":"1995","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jmgm.2025.109264_b158","doi-asserted-by":"crossref","first-page":"10067","DOI":"10.3390\/ijms130810067","article-title":"2 3-dihydro-1h-cyclopenta[b]quinoline derivatives as acetylcholinesterase inhibitors\u2014synthesis, radiolabeling and biodistribution","volume":"13","author":"Szyma\u0144ski","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmgm.2025.109264_b159","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103136","article-title":"Synthesis, physicochemical and biological evaluation of tacrine derivative labeled with technetium-99 m and gallium-68 as a prospective diagnostic tool for early diagnosis of alzheimer\u2019s disease","volume":"91","author":"Gniazdowska","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.jmgm.2025.109264_b160","doi-asserted-by":"crossref","DOI":"10.1063\/5.0213317","article-title":"Quantum chemical package jaguar: A survey of recent developments and unique features","volume":"161","author":"Cao","year":"2024","journal-title":"J. Chem. Phys."},{"issue":"22","key":"10.1016\/j.jmgm.2025.109264_b161","doi-asserted-by":"crossref","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J. Med. Chem."},{"issue":"42","key":"10.1016\/j.jmgm.2025.109264_b162","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J. Biological Chem."},{"issue":"4","key":"10.1016\/j.jmgm.2025.109264_b163","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/prot.10465","article-title":"Improved protein-ligand docking using gold","volume":"52","author":"Verdonk","year":"2003","journal-title":"Proteins"},{"issue":"3","key":"10.1016\/j.jmgm.2025.109264_b164","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3390\/ijms23031158","article-title":"Psma-targeting imaging and theranostic agents\u2014current status and future perspective","volume":"23","author":"Debnath","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.jmgm.2025.109264_b165","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.3390\/cancers13163967","article-title":"Psma-targeting radiopharmaceuticals for prostate cancer therapy: Recent developments and future perspectives","volume":"13","author":"Fakiri","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.jmgm.2025.109264_b166","article-title":"Glu-ureido-based inhibitors of prostate-specific membrane antigen: Lessons learned during the development of a novel class of low-molecular-weight theranostic radiotracers","volume":"58","author":"Kopka","year":"2017","journal-title":"J. Nucl. Med."},{"issue":"3","key":"10.1016\/j.jmgm.2025.109264_b167","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1021\/jm000406m","article-title":"Design of remarkably simple, yet potent urea-based inhibitors of glutamate carboxypeptidase ii (naaladase)","volume":"44","author":"Kozikowski","year":"2001","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.jmgm.2025.109264_b168","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1021\/jm800765e","article-title":"Interactions between human glutamate carboxypeptidase ii and urea-based inhibitors: Structural characterization","volume":"51","author":"Barinka","year":"2008","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.jmgm.2025.109264_b169","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/sj.emboj.7600969","article-title":"Structure of glutamate carboxypeptidase ii, a drug target in neuronal damage and prostate cancer","volume":"25","author":"Mesters","year":"2006","journal-title":"EMBO J."},{"issue":"12","key":"10.1016\/j.jmgm.2025.109264_b170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004586","article-title":"Autodockfr: Advances in protein-ligand docking with explicitly specified binding site flexibility","volume":"11","author":"Ravindranath","year":"2015","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jmgm.2025.109264_b171","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11307-023-01881-y","article-title":"The theranostic optimization of psma-gck01 does not compromise the imaging characteristics of [99mtc]tc-psma-gck01 compared to dedicated diagnostic [99mtc]tc-edda\/hynic-ipsma in prostate cancer","volume":"26","author":"Mamlins","year":"2024","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.jmgm.2025.109264_b172","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbrc.2023.02.003","article-title":"Evaluation of psma target diagnostic pet tracers for therapeutic monitoring of [177lu]ludotadipep of prostate cancer: Screening of psma target efficiency and biodistribution using [18f]dcfpyl and [68ga]psma-11","volume":"651","author":"Kim","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.jmgm.2025.109264_b173","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1021\/acs.molpharmaceut.2c00070","article-title":"Investigation of tumor cells and receptor\u2013ligand simulation models for the development of pet imaging probes targeting psma and grpr and a possible crosstalk between the two receptors","volume":"19","author":"Liolios","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jmgm.2025.109264_b174","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1039\/D1TB02651H","article-title":"Design and characterization of fibroblast activation protein targeted pan-cancer imaging agent for fluorescence-guided surgery of solid tumors","volume":"10","author":"Mukkamala","year":"2022","journal-title":"J. Mater. Chem. B"},{"issue":"1","key":"10.1016\/j.jmgm.2025.109264_b175","article-title":"Fibroblast activation protein inhibitor tracers and their preclinical, translational, and clinical status in china","volume":"65","author":"Zhao","year":"2024","journal-title":"J. Nucl. Med."},{"issue":"19","key":"10.1016\/j.jmgm.2025.109264_b176","doi-asserted-by":"crossref","first-page":"14028","DOI":"10.1021\/acs.jmedchem.1c01010","article-title":"Regulation of fibroblast activation protein-\u03b1 expression: Focus on intracellular protein interactions","volume":"64","author":"Juillerat-Jeanneret","year":"2021","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.jmgm.2025.109264_b177","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1021\/acs.bioconjchem.4c00426","article-title":"Fap-targeted fluorescent imaging agents to study cancer-associated fibroblasts in vivo","volume":"36","author":"Deutsch-Williams","year":"2025","journal-title":"Bioconjugate Chem."},{"issue":"6","key":"10.1016\/j.jmgm.2025.109264_b178","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1021\/acs.jmedchem.5c00132","article-title":"99Mtc-labeled quinolone-based novel skeletal tracers for tumor visualization through fibroblast activation protein","volume":"68","author":"Luo","year":"2025","journal-title":"J. Med. Chem."},{"issue":"XX","key":"10.1016\/j.jmgm.2025.109264_b179","first-page":"XX","article-title":"Preclinical characterization of novel fap-2286-based radioligand with albumin binder for improved tumor retention","volume":"XX","author":"Saito","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.jmgm.2025.109264_b180","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/molecules27010264","article-title":"Design, synthesis and preclinical assessment of 99mtc-ifap for in vivo fibroblast activation protein (fap) imaging","volume":"27","author":"Trujillo-Ben\u00edtez","year":"2022","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.jmgm.2025.109264_b181","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1021\/acssensors.1c01316","article-title":"Rational design, pharmacomodulation, and synthesis of [68ga]ga-alb-faptp-01, a selective tumor-associated fibroblast activation protein tracer for pet imaging of glioma","volume":"6","author":"Lin","year":"2021","journal-title":"ACS Sens."},{"issue":"12","key":"10.1016\/j.jmgm.2025.109264_b182","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1021\/acs.jmedchem.1c02162","article-title":"Rational design and pharmacomodulation of protein-binding theranostic radioligands for targeting the fibroblast activation protein","volume":"65","author":"Meng","year":"2022","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.jmgm.2025.109264_b183","doi-asserted-by":"crossref","first-page":"8614","DOI":"10.1021\/acs.jmedchem.3c00259","article-title":"High affinity and fap-targeted radiotracers: A potential design strategy to improve the pharmacokinetics and tumor uptake for fap inhibitors","volume":"66","author":"Wang","year":"2023","journal-title":"J. Med. Chem."},{"issue":"19","key":"10.1016\/j.jmgm.2025.109264_b184","doi-asserted-by":"crossref","first-page":"17785","DOI":"10.1021\/acs.jmedchem.4c01812","article-title":"68Ga\/177lu-labeled theranostic pair for targeting fibroblast activation protein with improved tumor uptake and retention","volume":"67","author":"Huang","year":"2024","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.jmgm.2025.109264_b185","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1021\/ci500118s","article-title":"Docking covalent inhibitors: A parameter free approach to pose prediction and scoring","volume":"54","author":"Zhu","year":"2014","journal-title":"J. Chem. Inf. Model."},{"issue":"7","key":"10.1016\/j.jmgm.2025.109264_b186","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3390\/jpm12071073","article-title":"Atlas of pd-l1 for pathologists: Indications, scores, diagnostic platforms and reporting systems","volume":"12","author":"Marletta","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.jmgm.2025.109264_b187","doi-asserted-by":"crossref","first-page":"9086","DOI":"10.1021\/acs.analchem.0c01291","article-title":"Epitope and paratope mapping of pd-1\/nivolumab by mass spectrometry-based hydrogen-deuterium exchange, cross-linking, and molecular docking","volume":"92","author":"Zhang","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jmgm.2025.109264_b188","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1401515","article-title":"Navigating the landscape of pd-1\/pd-l1 imaging tracers: from challenges to opportunities","volume":"11","author":"Badenhorst","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.jmgm.2025.109264_b189","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1296341","article-title":"Pd-1 and pd-l1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment","volume":"14","author":"Parvez","year":"2023","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.jmgm.2025.109264_b190","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3390\/ph17070906","article-title":"99Mtc-labeled cyclic peptide targeting pd-l1 as a novel nuclear imaging probe","volume":"17","author":"Fan","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jmgm.2025.109264_b191","series-title":"Mopac2016","author":"Stewart","year":"2016"},{"issue":"13","key":"10.1016\/j.jmgm.2025.109264_b192","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.3390\/ijms25136926","article-title":"Transporter proteins as therapeutic drug targets\u2014with a focus on sglt2 inhibitors","volume":"25","author":"Komaniecka","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmgm.2025.109264_b193","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.852938","article-title":"Cell surface transporters and novel drug developments","volume":"13","author":"Carmichael","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.jmgm.2025.109264_b194","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/cpt.435","article-title":"Transporters as drug targets in neurological diseases","volume":"100","author":"Qosa","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"issue":"16","key":"10.1016\/j.jmgm.2025.109264_b195","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1111\/febs.14577","article-title":"Glucose transporters in cancer - from tumor cells to the tumor microenvironment","volume":"285","author":"Ancey","year":"2018","journal-title":"FEBS J."},{"issue":"16","key":"10.1016\/j.jmgm.2025.109264_b196","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.3390\/cancers13164184","article-title":"Glucose transporters as a target for anticancer therapy","volume":"13","author":"Pliszka","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jmgm.2025.109264_b197","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2022.110553","article-title":"Evaluation of f-18 fdg radiopharmaceuticals through molecular docking and radiation effects","volume":"191","author":"Kilicoglu","year":"2023","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.jmgm.2025.109264_b198","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature13306","article-title":"Crystal structure of the human glucose transporter glut1","volume":"510","author":"Deng","year":"2014","journal-title":"Nature"},{"issue":"7573","key":"10.1016\/j.jmgm.2025.109264_b199","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nature14909","article-title":"Structure and mechanism of the mammalian fructose transporter glut5","volume":"526","author":"Nomura","year":"2015","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jmgm.2025.109264_b200","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/acs.jcim.1c00854","article-title":"Sinaps: A software tool for analysis and visualization of interaction networks of molecular dynamics simulations","volume":"62","author":"Bedart","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2025.109264_b201","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1150355","article-title":"Overview of the structure and function of the dopamine transporter and its protein interactions","volume":"14","author":"Nepal","year":"2023","journal-title":"Front. Physiol."},{"issue":"7","key":"10.1016\/j.jmgm.2025.109264_b202","article-title":"Enhancing 3d dopamine transporter imaging as a biomarker for parkinson\u2019s disease via self-supervised learning with diffusion models","volume":"6","author":"Won","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.jmgm.2025.109264_b203","series-title":"Kode srl","author":"for Molecular Descriptor Calculation","year":"2025"},{"issue":"13","key":"10.1016\/j.jmgm.2025.109264_b204","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/jcc.23576","article-title":"Qsarins-chem: Insubria datasets and new qsar\/qspr models for environmental pollutants in qsarins","volume":"35","author":"Gramatica","year":"2014","journal-title":"J. Comput. Chem."},{"issue":"29","key":"10.1016\/j.jmgm.2025.109264_b205","doi-asserted-by":"crossref","first-page":"15936","DOI":"10.1021\/jacs.3c03749","article-title":"Discovery of high-affinity amyloid ligands using a ligand-based virtual screening pipeline","volume":"145","author":"Chisholm","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"18","key":"10.1016\/j.jmgm.2025.109264_b206","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1021\/ja00226a005","article-title":"Comparative molecular field analysis (comfa). 1. effect of shape on binding of steroids to carrier proteins","volume":"110","author":"Cramer","year":"1988","journal-title":"J. Am. Chem. Soc."},{"issue":"24","key":"10.1016\/j.jmgm.2025.109264_b207","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1021\/jm00050a010","article-title":"Molecular similarity indices in a comparative analysis (comsia) of drug molecules to correlate and predict their biological activity","volume":"37","author":"Klebe","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109264_b208","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","article-title":"Structures of \u03b1-synuclein filaments from multiple system atrophy","volume":"585","author":"Schweighauser","year":"2020","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.jmgm.2025.109264_b209","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2024.05.006","article-title":"Imaging \u03b1-synuclein pathologies in animal models and patients with parkinson\u2019s and related diseases","volume":"112","author":"Endo","year":"2024","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.jmgm.2025.109264_b210","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nsmb.3194","article-title":"Solid-state nmr structure of a pathogenic fibril of full-length human alpha-synuclein","volume":"23","author":"Tuttle","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"15","key":"10.1016\/j.jmgm.2025.109264_b211","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.1021\/acs.jctc.4c00134","article-title":"Do all paths lead to rome? how reliable is umbrella sampling along a single path?","volume":"20","author":"Aho","year":"2024","journal-title":"J. Chem. Theory Comput."},{"issue":"8","key":"10.1016\/j.jmgm.2025.109264_b212","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/jcc.540130812","article-title":"The weighted histogram analysis method for free-energy calculations on biomolecules. i. the method","volume":"13","author":"Kumar","year":"1992","journal-title":"J. Comput. Chem."},{"issue":"4","key":"10.1016\/j.jmgm.2025.109264_b213","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/ird3.76","article-title":"Embracing artificial intelligence design for better radiopharmaceuticals","volume":"2","author":"Tao","year":"2024","journal-title":"iRADIOLOGY"},{"key":"10.1016\/j.jmgm.2025.109264_b214","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41568-024-00694-7","article-title":"A guide to artificial intelligence for cancer researchers","volume":"24","author":"Perez-Lopez","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jmgm.2025.109264_b215","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41592-025-02635-0","article-title":"The need to implement fair principles in biomolecular simulations","volume":"22","author":"Amaro","year":"2025","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.jmgm.2025.109264_b216","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1021\/acs.molpharmaceut.4c00991","article-title":"Establishing a pharmacoinformatics repository of approved medicines: A database to support drug product development","volume":"22","author":"Murray","year":"2025","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.jmgm.2025.109264_b217","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/bib\/bbaa003","article-title":"Exploration of databases and methods supporting drug repurposing: a comprehensive survey","volume":"22","author":"Tanoli","year":"2021","journal-title":"Brief. Bioinform."},{"issue":"1","key":"10.1016\/j.jmgm.2025.109264_b218","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202400227","article-title":"Improving molecular design with direct inverse analysis of qsar\/qspr model","volume":"44","author":"Shino","year":"2025","journal-title":"Mol. Inf."},{"key":"10.1016\/j.jmgm.2025.109264_b219","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107920","article-title":"Molecular tweaking by generative cheminformatics and ligand\u2013protein structures for rational drug discovery","volume":"153","author":"Nangia","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"12","key":"10.1016\/j.jmgm.2025.109264_b220","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.1021\/acs.jcim.0c01041","article-title":"tmqm dataset\u2014quantum geometries and properties of 86k transition metal complexes","volume":"60","author":"Balcells","year":"2020","journal-title":"J. Chem. Inf. Model."},{"issue":"3","key":"10.1016\/j.jmgm.2025.109264_b221","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1021\/acs.jmedchem.7b01473","article-title":"Metaqsar: An integrated database engine to manage and analyze metabolic data","volume":"61","author":"Pedretti","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109264_b222","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41597-022-01261-1","article-title":"Ab-db: Force-field parameters, md trajectories, qm-based data, and descriptors of antimicrobials","volume":"9","author":"Gervasoni","year":"2022","journal-title":"Sci. Data"},{"key":"10.1016\/j.jmgm.2025.109264_b223","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41597-022-01390-7","article-title":"Qmugs, quantum mechanical properties of drug-like molecules","volume":"9","author":"Isert","year":"2022","journal-title":"Sci. Data"},{"issue":"22","key":"10.1016\/j.jmgm.2025.109264_b224","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1021\/acs.jcim.2c01422","article-title":"The (re)-evolution of quantitative structure\u2013activity relationship (qsar) studies propelled by the surge of machine learning methods","volume":"62","author":"Soares","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2025.109264_b225","doi-asserted-by":"crossref","DOI":"10.1016\/j.cplett.2024.141239","article-title":"Optimization of monte carlo method-based qspr modeling for lipophilicity in radiopharmaceuticals","volume":"843","author":"Bamdi","year":"2024","journal-title":"Chem. Phys. Lett."},{"issue":"15","key":"10.1016\/j.jmgm.2025.109264_b226","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1021\/acs.jcim.4c00614","article-title":"Integrating prior chemical knowledge into the graph transformer network to predict the stability constants of chelating agents and metal ions","volume":"64","author":"Chen","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2025.109264_b227","series-title":"The iupac stability constants database","author":"Pettit","year":"2006"},{"key":"10.1016\/j.jmgm.2025.109264_b228","series-title":"RDKit: open-source cheminformatics","year":"2013"},{"key":"10.1016\/j.jmgm.2025.109264_b229","doi-asserted-by":"crossref","DOI":"10.1021\/acs.chemrev.5c00641","article-title":"Chemical tools to characterize the coordination chemistry of radionuclides for radiopharmaceutical applications","author":"Boros","year":"2025","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jmgm.2025.109264_b230","first-page":"1","article-title":"Opportunities and challenges for metal chemistry in molecular imaging: from gamma camera imaging to pet and multimodality imaging","volume":"68","author":"Southworth","year":"2018","journal-title":"Adv. Inorg. Chem."},{"issue":"4","key":"10.1016\/j.jmgm.2025.109264_b231","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/jnt6040027","article-title":"Theranostic nanoplatforms in nuclear medicine: Current advances, emerging trends, and perspectives for personalized oncology","volume":"6","author":"Salgueiro","year":"2025","journal-title":"J. Nanotheranostics"},{"key":"10.1016\/j.jmgm.2025.109264_b232","article-title":"Chitosan\/sirna complex in mimetic high-density lipoproteins as specific\/hybrid transfection technology for sr-b1 expressing cancer cells","volume":"101","author":"Aranda-Lara","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"6","key":"10.1016\/j.jmgm.2025.109264_b233","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/wnan.1402","article-title":"Nanoparticles and radiotracers: Advances toward radio-nanomedicine","volume":"8","author":"Pratt","year":"2016","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"7","key":"10.1016\/j.jmgm.2025.109264_b234","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3390\/pharmaceutics17070912","article-title":"Nanoradiopharmaceuticals: Design principles, radiolabeling strategies, and biomedicine applications","volume":"17","author":"N\u00fa\u00f1ez Salinas","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jmgm.2025.109264_b235","article-title":"Mathematical models for optical imaging applications of light emission from 177lu2o3 nanoparticles","volume":"402","author":"Ancira-Cortez","year":"2025","journal-title":"Mater. Lett."},{"key":"10.1016\/j.jmgm.2025.109264_b236","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2025.1528826","article-title":"Integrating computational insights in gold nanoparticle-mediated drug delivery: enhancing efficacy and precision","volume":"7","author":"Alalmaie","year":"2025","journal-title":"Front. Med. Technol."},{"key":"10.1016\/j.jmgm.2025.109264_b237","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10311-020-01071-0","article-title":"Preparation and antibacterial properties of gold nanoparticles: a review","volume":"19","author":"Gu","year":"2021","journal-title":"Env. Chem. Lett."},{"key":"10.1016\/j.jmgm.2025.109264_b238","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.addr.2019.05.001","article-title":"The significance of artificial intelligence in drug delivery system design","volume":"151\u2013152","author":"Hassanzadeh","year":"2019","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326325003249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326325003249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:50:05Z","timestamp":1769028605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326325003249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":238,"alternative-id":["S1093326325003249"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2025.109264","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational studies of target-specific radiopharmaceuticals for theranostics","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2025.109264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109264"}}